ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: Surmodics Inc (SRDX) Report Updated: Nov 28, 2016 | Print This Page

Get more stock ratings by Louis Navellier

Surmodics Inc (SRDX)

Rating: Hold Volatility: Conservative
Total Grade: C Industry: Health Care Equipment & Supplies
Competitors: ISRG,MZOR,INGN,LNTH

Stock Analysis

Rating: Monthly View

A
B
C
D
F
December January February March April May June July August September October November

Rating: Weekly View

This Week: C down downgrade
Last Week: B same no change
Two Weeks Ago: B up no change
service keys

Surmodics Inc© quotemedia

Company Profile

SurModics, Inc., together with its subsidiaries, provides surface modification and in vitro diagnostic technologies to the healthcare industry worldwide. It operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, urology, and other markets. This segment also engages in the contract research, development, and manufacture of percutaneous transluminal angioplasty balloon catheters for use in various interventional cardiology applications. The Vitro Diagnostics segment provides component products and technologies that include protein stabilization reagents, substrates, antigens, and surface coatings for diagnostic immunoassay and molecular tests, as well as to the diagnostic, biomedical research, and life science markets. The company markets its technologies and products through direct sales force consisting of sales professionals. SurModics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.